McBride (MCB) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
26 Feb, 2026Executive summary
Delivered strong financial and operational performance for the third consecutive year, with profitability at double historic averages and robust cash generation.
Private label market share reached 36.1%, outperforming brands and supported by a strong pipeline of new business wins for H2 FY26.
SAP S/4HANA ERP system successfully launched in the UK, stabilizing quickly and supporting future efficiency and operational excellence, with further rollout planned.
Transformation programmes delivered cumulative net benefits, with further progress expected by FY28.
Nearly £13 million deployed in shareholder returns via dividends, share buybacks, and EBT purchases.
Financial highlights
Revenue for H1 FY26 was £475.2m, up £3.8m (+0.8%) year-over-year, driven by private label and contract manufacturing growth.
Adjusted EBITDA held steady at £41.8m (8.8% margin), consistent with the prior year.
Adjusted operating profit slightly down to £31.5m, mainly due to SAP implementation impact.
Adjusted basic EPS at 10.8p (2024: 11.9p), reflecting a higher tax rate.
Free cash flow generation of £24.2m; net debt increased to £120.6m, representing 1.4x adjusted EBITDA.
Outlook and guidance
Full-year results expected to be in line with analysts’ expectations, with positive momentum anticipated for FY27.
New business wins and contract launches in H2 and FY27 expected to drive growth.
Material costs anticipated to remain stable, with inflation managed through tight overhead control.
Ongoing transformation initiatives and SAP rollout to deliver further efficiencies and risk reduction.
Latest events from McBride
- FY26 and FY27 adjusted EBITA guidance cut by 5–10% due to input cost pressures; Eurotab deal closing soon.MCB
Trading update - Adjusted operating profit on track, with revenue and volume growth supporting future gains.MCB
Trading update - Revenue up, profit steady, cash strong, dividend reinstated, private label at record high.MCB
H2 2025 - Revenue up, net debt down, and contract manufacturing volumes surged 48.9%.MCB
H2 2025 TU - Profit growth, margin recovery, and lower net debt drive a confident outlook.MCB
H2 2024 - Profit, cash flow, and private label growth enabled dividend plans amid ongoing transformation.MCB
H1 2025